US Patent Issued to TECHNION RESEARCH AND DEVELOPMENT FOUNDATION on March 24 for "Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors" (Israeli Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,892, issued on March 24, was assigned to TECHNION RESEARCH AND DEVELOPMENT FOUNDATION Ltd. (Haifa, Israel).

"Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors" was invented by Shai Berlin (Haifa, Israel), Ido Carmi (Haifa, Israel) and Shaden Zoabi (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are modified forms of Conantokin peptides, including, modified Con-P peptides, nucleic acids encoding the same and compositions thereof. Further provided are nucleic acid molecules encoding for chimeric modified conantokin polypeptides to be expressed in or on a membrane of a t...